HealthEquity Analysts Boost Their Forecasts After Upbeat Earnings

Core Insights - HealthEquity, Inc. reported better-than-expected first-quarter results with earnings of 97 cents per share, surpassing the consensus estimate of 88 cents [1] - Quarterly revenue reached $330.8 million, exceeding the Street estimate of $321.17 million [1] Financial Performance - The company achieved record quarterly revenue and record Adjusted EBITDA in the first quarter of fiscal 2026 [2] - HealthEquity raised its fiscal 2026 adjusted EPS guidance to a new range of $3.61 to $3.78, compared to the previous range of $3.57 to $3.74 and the analyst estimate of $3.63 [2] - The revenue outlook for fiscal 2026 remains between $1.28 billion and $1.3 billion, aligning with the $1.3 billion estimate [2] Stock Market Reaction - Following the earnings announcement, HealthEquity shares increased by 9.8% to $113.94 [3] - Analysts adjusted their price targets for HealthEquity after the earnings report [3] Analyst Ratings and Price Targets - JMP Securities analyst maintained a Market Outperform rating and raised the price target from $110 to $117 [5] - B of A Securities analyst maintained a Buy rating and increased the price target from $110 to $125 [5] - RBC Capital analyst maintained an Outperform rating and raised the price target from $112 to $117 [5] - Goldman Sachs analyst maintained a Neutral rating and increased the price target from $94 to $104 [5]